Are There Any Epigenetic Similarities Between Treatment Unresponsive Sarcoidosis, COPD and Severe Asthma?
-
Esmaeil Mortaz
,
Alireza Eslaminejad
,
Mohammad Varahram
,
Jalal Heshmatnia
,
Atefeh Abedini
,
Arda Kiani
,
Aliakbar Velayati
,
Johan Garssen
,
Ian M. Adcock
Abstract
No Abstract
1. Mortaz E, Sereshki HA, Abedini A, Kiani A, Mirsaeidi M, Soroush D, et al. Alternation of serum TNF-, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis. J Inflamm (Lond) 2015; 12:21.
2. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis:a systematic review. JAMA 2002;287(10):1301–7.
3. Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006; 28:627–36.
4. Liu Y, Li H, Xiao T, Lu Q. Epigenetics in Immune- Mediated Pulmonary Diseases. Clin Rev Allergy Immunol 2013; 45(3):314–30.
5. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2013; 131(3):636-45.
6. Yang IV, Schwartz DA. Epigenetics of idiopathic pulmonary fibrosis.Transl Res 2015; 165(1):48-60.
7. Mortaz E, Masjedi MR, Barnes PJ, Adcock IM.Epigenetics and Chromatin Remodeling Play a Role in Lung Disease. Tanaffos 2011; 10(4):7–16.
8. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy ClinImmunol 2013; 131(3):636-4.
9. Tripathi SK, Lahesmaa R. Transcriptional and epigenetic regulation of T-helper lineage specification. Immunol Rev 2014; 261(1):62–83.
10. Moncef Zouali, The Epigenetics of Autoimmune Diseases.472 pages April 2009. WILEY-BLACKWELL press 2009.
11. Kitagawa Y, Ohkura N, Sakaguchi S. Molecular determinants of regulatory T celldevelopment: the essential roles of epigenetic changes. Front Immunol 2013; 10(4):106.
12. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403(6765):41–5.
13. Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readersoflysine acetylation. Nat Rev Drug Discov 2014; 13(5):337-56.
14. Feller C, Forné I, Imhof A, Becker PB. Global and specific responses of thehistoneacetylome to systematic perturbation. Mol Cell 2015; 57(3):559-71.
15. Su RC, Becker AB, Kozyrskyj AL, Hayglass KT. Altered epigenetic regulation andincreasing severity of bronchial hyperresponsiveness in atopic asthmaticchildren. J Allergy ClinImmunol 2009; 124(5):1116-8.
16. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352(19):1967-76.
17. Adcock IM. Histone deacetylase inhibitors as novel anti- inflammatory agents. Curr Opin Investig Drugs 2006;7(11):966–73.
18. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF- kappaB suppression. J Exp Med 2006; 203(1):7–13.
19. Kobayashi Y, Bossley C, Gupta A, Akashi K, Tsartsali L, Mercado N, et al. Passive smoking impairs histone deacetylase-2 in children with severe asthma. Chest 2014;145(2):305-12.
20. To Y, Elliott WM, Ito M, et al. Total histone deacetylase activity decreases with increasing clinical stage of COPD.Am J Respir Crit Care Med 2004; 169:A276.
21. Barnes PJ. Reduced histone deacetylase in COPD: clinical implications. Chest 2006; 129(1):151–5.
22. Farria A, Li W, Dent SY. KATs in cancer: functions and therapies. Oncogene 2015; doi:10.1038/onc.2014.453.
23. Philp A, Rowland T, Perez-Schindler J, Schenk S.Understanding the acetylome: translating targeted proteomics into meaningful physiology. Am J Physiol Cell Physiol 2014; 307(9):C763-73.
24. Charron CE, Chou PC, Coutts DJ, Kumar V, To M, Akashi K, et al. Hypoxia-inducible factor 1alpha induces corticosteroid-insensitive inflammation via reduction of histone deacetylase-2 transcription. J Biol Chem 2009;284(52):36047–54.
25. Yang IV, Schwartz DA. Epigenetics of idiopathic pulmonary fibrosis. Transl Res 2015; 165(1):48-60.
26. Maeda T, Guan JZ, Higuchi Y, Oyama J, Makino N.Agingrelated alterations of subtelomeric methylation in sarcoidosis patients. J Gerontol A BiolSci Med Sci 2009;64(7):752–60.
27. Teirilä L, Karvala K, Ahonen N, Riska H, Pietinalho A, Tuominen P, et al. Proteomic Changes of Alveolar Lining Fluid in Illnesses Associated with Exposure to Inhaled Non-Infectious Microbial Particles. PLoS One 2014; 9(7):e102624.
28. Kouzarides T. Histone methylation in transcriptional control. CurrOpin Genet Dev 2002; 12:198–209.
29. Rea S, Eisenhaber F, O’Carroll D, Strahl BD, Sun ZW,Schmid M, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000;406(6796):593–9.
30. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150(1):12-27.
31. Dakhlallah D, Batte K, Wang Y, Cantemir-Stone CZ, Yan P, Nuovo G, et al. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. Am J RespirCrit Care Med 2013; 187(4):397-405.
32. Booton R, Lindsay MA. Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. Chest 2014; 146(1):193-204.
33. Collison A, Mattes J, Plank M, Foster PS. Inhibition of house dustmite-induced allergic airways disease by antagonism of microRNA-145 is comparableto glucocorticoid treatment. J Allergy Clin Immunol 2011;128(1):160-7.
34. Crouser ED1, Julian MW, Crawford M, Shao G, Yu L, Planck SR, Rosenbaum JT, Patrick Nana-Sinkam S. Differential expression of microRNA and predicted targets in pulmonary sarcoidosis. Biochem Biophys Res Commun 2012; 417(2):886-91.
35. Liang L, Willis-Owen SA, Laprise C, Wong KC, Davies GA, Hudson TJ, et al. An epigenome-wide association study of total serum immunoglobulin E concentration. Nature 2015; 520(7549):670-4.
36. Gustafsson M, Nestor CE, Zhang H, Barabási AL, Baranzini S, Brunak S, et al. Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Med 2014; 6(10):82.
| Files | ||
| Issue | Vol 14, No 5 (2015) | |
| Section | Short Perspective | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
